Navigation Links
SuperNova Diagnostics® to Present at the Rodman & Renshaw Global Investment Conference
Date:9/6/2011

t sacrificing a dynamic range of measurements.  SuperNova can be utilized in a wide range of diagnostic formats (lateral flow, self-contained cartridges, microtitre, microarrays, closed systems, research products and OEM). SuperNova® — Putting the Laboratory in the Palm of Your Hand®.  For additional information, please visit www.supernovadiagnostics.com.

Media Contacts:
Tiberend Strategic Advisors, Inc.
Jason Rando
(212) 827-0020
jrando@tiberend.com


'/>"/>
SOURCE SuperNova Diagnostics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. SuperNova Diagnostics® Announces Agreement with KSB Diagnostics of China
2. SuperNova Diagnostics® to Present at Biotech Showcase™ 2011 During J.P. Morgan Healthcare Conference January 10-13
3. Dilon Diagnostics® Partners With PenRad®
4. Thoratec Announces Presentations at Upcoming Investor Conferences
5. Keryx Biopharmaceuticals Announces Upcoming Corporate Presentations
6. Access Pharmaceuticals to Present at Rodman & Renshaw Annual Global Investment Conference on Monday, September 12th in New York City
7. ADVENTRX Pharmaceuticals to Present at the Rodman & Renshaw Annual Global Investment Conference on September 12
8. Golden Meditech Celebrates Grand Opening of Taiwan Representative Office
9. Lexicon Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference
10. Onyx Pharmaceuticals to Present at Two Upcoming Healthcare Conferences
11. Amgen to Present at the Stifel Nicolaus Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... Ga., March 4, 2015  Halyard Health, Inc. (NYSE: ... and provided its 2015 outlook and related key planning ... Halyard Health as we report our fourth quarter results, ... Chairman and CEO. "We executed a smooth separation from ... the spin-off. We delivered sales growth and margin improvement ...
(Date:3/4/2015)... BOSTON , March 4, 2015   InspireMD, ... leader in embolic protection systems ("EPS"), today announced that ... up to approximately 34 million shares of common stock ... shares of common stock in a public offering.  The ... price of $0.40 per share, and each purchaser will ...
(Date:3/4/2015)... 4, 2015 Oramed Pharmaceuticals Inc. ... clinical-stage pharmaceutical company focused on the development of oral ... participate in the upcoming 27 th Annual ROTH ... Dana Point, CA.  Dr. Michael Berelowitz ... will present a corporate overview on March 10, 2015. ...
Breaking Medicine Technology:Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 2Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 3Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 4Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 5Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 6Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 7Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 8Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 9Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 10Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 11Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 12Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 13Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 14Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 15Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 16Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 17Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 18Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 19Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 20Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 21Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 22Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 23Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 24Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 25Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 26Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 27Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 28Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 29Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 30Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 31InspireMD Announces Public Offering for Approximately $13.5 Million 2InspireMD Announces Public Offering for Approximately $13.5 Million 3InspireMD Announces Public Offering for Approximately $13.5 Million 4Oramed to Present at the ROTH Conference 2Oramed to Present at the ROTH Conference 3
... SIRO Clinpharm, a leading full service Clinical Research Organization ... SIRO has developed a long term plan to align with ... charter is to transform SIRO into a global leader in ... continuing to build and enhance the biopharma service catalog for ...
... 2012  Amgen Inc. ("Amgen") (NASDAQ: AMGN ) announced ... tender offer (the "Offer") by a wholly owned subsidiary, "Merger ... Micromet, Inc. ("Micromet") (NASDAQ: MITI ) for $11.00 ... 12:00 midnight, New York City time, at the end of ...
Cached Medicine Technology:SIRO Clinpharm Announces Appointment of Gopakumar Menon as Chief Executive Officer to Lead the Global Clinical Research Organization 2Amgen Completes Tender Offer for Outstanding Shares of Micromet, Inc. 2Amgen Completes Tender Offer for Outstanding Shares of Micromet, Inc. 3Amgen Completes Tender Offer for Outstanding Shares of Micromet, Inc. 4
(Date:3/4/2015)... March 04, 2015 State officials have ... the School of Public Health at Georgia State University, ... were awarded by Georgia’s Division of Family and Children ... the DFCS Call Center. , The 1-800-CHILDREN Helpline ... providing information and referral services that promote the wellbeing ...
(Date:3/4/2015)... March 04, 2015 The popular all-natural ... their new L-Style Revolution™ Program. The customized program provides ... women of all health and fitness levels to follow ... faster than traditional methods. , “We’re really proud to ... plans based on award winning techniques to help people ...
(Date:3/4/2015)... March 04, 2015 Columbus is no stranger ... prevalence of cocaine addiction, and suffers from the potential ... on Feb. 27th, the DEA revealed that Kratom is a ... herbal tea; the newly introduced herb from Southeast Asia acts ... heightened doses. WKYC notes kratom foments symptoms similar to heroin ...
(Date:3/4/2015)... Vancouver, BC (PRWEB) March 04, 2015 ... Research , millions of people in the U.S. suffer ... acid reflux. Medications are commonly prescribed to control acid ... invasive surgical procedures can overly correct the problem and ... A Market Opportunity, GERD occurs when the lower esophageal ...
(Date:3/4/2015)... Jeannie Mai, TV personality, fashion maven, and co-host ... of the print publication. Mai embraces the overall theme of ... for clothes and personal care products. In an exclusive interview, ... to an organic diet. She mentions, “Having an organic lifestyle ... but also now as I’m a full time student at ...
Breaking Medicine News(10 mins):Health News:State Funds Child Abuse Helpline Housed At Georgia State 2Health News:The Makers of Liporidex, The Popular Sports Nutrition Supplement Brand, Launches Its New L-Style Revolution™ Diet & Exercise Program That Promises Turbo Charged Results 2Health News:Columbus, OH Combats the Sale of Kratom as a Drug, Harbor Village Detox Stresses Caution 2Health News:New and Proven Acid Reflux Treatments Offer Relief to Millions of Americans 2Health News:New and Proven Acid Reflux Treatments Offer Relief to Millions of Americans 3
... Today, SOUTH SAN FRANCISCO, Calif., Feb. 28 Cell,Genesys, ... the,fourth quarter and full year ended December 31, 2007. The ... diluted share), for the fourth,quarter of 2007, compared to a ... the corresponding period in 2006. The net loss for the,year ...
... MOUNTAIN VIEW, Calif., Feb. 28 MAP,Pharmaceuticals, Inc. (Nasdaq: ... quarter and year ended December 31, 2007., The ... December 31, 2007,was $14.9 million and $40.1 million, respectively, ... periods in 2006. MAP,Pharmaceuticals had cash, cash equivalents and ...
... Feb. 28 Closer,analysis of the patent office "non-final" ... the Wisconsin Alumni Research Foundation (WARF),shows the following gains ... was abandoned showing it was underserved,and new amended claims ... all embryonic stem cells no matter how,they are derived, ...
... 28, 2008) -- NewYork-Presbyterian Hospital/Weill Cornell Medical Center announced ... Forbes Holdings Inc., has made a $50 million gift ... NewYork-Presbyterian Hospital and Weill Cornell Medical College, in support ... the world. The gift will establish the Ronald O. ...
... COLUMBIA, Mo. University of Missouri scientist Kattesh ... using gold salts, soybeans and water. Kattis research ... could have major applications in several disciplines. , ... small they cannot be seen by the naked ...
... YORK, February 28 Ten prominent journalists from the ... for the fourth annual TempletonCambridge Journalism Fellowships in Science ... 2004, the fellowships include a program of research and ... The 2008 fellows were announced today by the New ...
Cached Medicine News:Health News:Cell Genesys Reports Fourth Quarter and Year-End 2007 Results 2Health News:Cell Genesys Reports Fourth Quarter and Year-End 2007 Results 3Health News:Cell Genesys Reports Fourth Quarter and Year-End 2007 Results 4Health News:Cell Genesys Reports Fourth Quarter and Year-End 2007 Results 5Health News:Cell Genesys Reports Fourth Quarter and Year-End 2007 Results 6Health News:MAP Pharmaceuticals Reports 2007 Fourth Quarter and Year End Financial Results 2Health News:MAP Pharmaceuticals Reports 2007 Fourth Quarter and Year End Financial Results 3Health News:MAP Pharmaceuticals Reports 2007 Fourth Quarter and Year End Financial Results 4Health News:MAP Pharmaceuticals Reports 2007 Fourth Quarter and Year End Financial Results 5Health News:MAP Pharmaceuticals Reports 2007 Fourth Quarter and Year End Financial Results 6Health News:MAP Pharmaceuticals Reports 2007 Fourth Quarter and Year End Financial Results 7Health News:Closer Analysis Shows Consumer Groups Make Gains in Stem Cell Patent Challenges Against WARF; Appeal Still Planned Against Narrowed Claims 2Health News:$50 million gift to NewYork-Presbyterian Hospital/Weill Cornell Medical Center 2Health News:$50 million gift to NewYork-Presbyterian Hospital/Weill Cornell Medical Center 3Health News:$50 million gift to NewYork-Presbyterian Hospital/Weill Cornell Medical Center 4Health News:$50 million gift to NewYork-Presbyterian Hospital/Weill Cornell Medical Center 5Health News:Breakthroughs in nanotechnology on edge of 'knowledge frontier' 2Health News:Breakthroughs in nanotechnology on edge of 'knowledge frontier' 3Health News:4th annual Templeton-Cambridge fellowships awarded to 10 noted journalists 2Health News:4th annual Templeton-Cambridge fellowships awarded to 10 noted journalists 3Health News:4th annual Templeton-Cambridge fellowships awarded to 10 noted journalists 4
... a long term, quality solution based on ... posterior stabilized and anatomically correct cruciate retaining ... flexibility needed to address patients' needs. In ... keeps the user in mind and promotes ...
... StelKast's Proven Knee System is a long ... proven design. Available in both posterior stabilized ... Proven Knee System provides the flexibility needed ... standardization and ease of identification keeps the ...
... MJS Anatomic Knee system was designed ... between all articulating surfaces, to minimize ... to achieve a well balanced knee ... tension. The MJS Knee system allows ...
... The FluoroNav Virtual ... Surgical Navigation Technologies has ... with exciting technology features ... images and three-dimensional models ...
Medicine Products: